Pooled Neo-Antigen Antibody Treatment for Cancer
Antibodies are highly capable of initiating cytotoxicity of target cells, but a fundamental unresolved property of antibody treatment of cancer is the heterogeneity of the cancer cell population of the tumor, and subsequent tumor resistance to the treatment. Using multiple cell surface related neo-antigens, each with a single amino-acid change, a cocktail...
Published: 2/25/2025
|
Inventor(s): David Krag, Girja Shukla, Stephanie Pero, Yujing Sun*
Keywords(s):
Category(s): Technology Classifications > Biomedical
|